2500 Meridian Pkwy
Suite 175
Durham, NC 27713
United States
https://polarean.com
Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 28
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Kenneth Paul West | Chairman of the Board | 44,79k | N/A | 1957 |
Dr. Bastiaan Driehuys Ph.D. | Founder, Chief Scientific Officer & Director | 28,81k | N/A | 1970 |
Mr. Charles Fremont Osborne Jr. | CFO & Director | 270k | N/A | 1966 |
Dr. Christopher Richard Von Jako Ph.D. | CEO & Director | N/A | N/A | 1970 |
Mr. Neil Wadehra | Vice President of Operations | N/A | N/A | 1980 |
Mr. Alex Dusek | Chief Commercial Officer | N/A | N/A | 1967 |
Mr. Stephen Austin | Company Secretary | N/A | N/A | N/A |
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas polarizer devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; and measurement station, chest coil, and dose delivery inhalation bags. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.
Polarean Imaging plcs ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.